Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Below 200 Day Moving Average of $565.28

Bio-Rad Laboratories, Inc. (NYSE:BIO.BGet Rating) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $565.28 and traded as low as $484.36. Bio-Rad Laboratories shares last traded at $484.36, with a volume of 1,519 shares changing hands.

Analysts Set New Price Targets

Separately, TheStreet cut Bio-Rad Laboratories from a “b” rating to a “c+” rating in a research note on Thursday, April 28th.

Bio-Rad Laboratories Stock Down 2.7 %

The company has a quick ratio of 4.16, a current ratio of 5.10 and a debt-to-equity ratio of 0.12. The firm’s 50-day moving average price is $503.49 and its 200 day moving average price is $565.28. The firm has a market cap of $14.50 billion, a P/E ratio of -99.25 and a beta of 0.79.

Bio-Rad Laboratories (NYSE:BIO.BGet Rating) last announced its quarterly earnings results on Thursday, April 28th. The company reported $4.94 earnings per share (EPS) for the quarter. The company had revenue of $700.06 million during the quarter. Bio-Rad Laboratories had a positive return on equity of 3.66% and a negative net margin of 3.49%.

About Bio-Rad Laboratories

(Get Rating)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Read More

Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with's FREE daily email newsletter.